New endocrine drugs for treatment of advanced breast cancer (Q37938324)

25 August 2017

1 reference

title

New endocrine drugs for treatment of advanced breast cancer (English)

1 reference

25 August 2017

1

Lønning PE

1 reference

25 August 2017

publication date

1 January 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

29

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

379-386

1 reference

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Trioxifene mesylate in the treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

The Hormonal Activity of the Postmenopausal Ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

The metabolism of estradiol; oral compared to intravenous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Hydrocortisone alone vs hydrocortisone plus aminogluthethimide: a comparison of the endocrine effects in postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ4- and Δ5-Steroids in Postmenopausal Women Treated for Breast Carcinoma*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Effects of aminoglutethimide on adrenal steroid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Prednisolone improves the response to primary endocrine treatment for advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

A dose response evaluation of delta-1-testololactone in advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Inhibition of aromatase with CGS 16949A in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Analogues of aminoglutethimide: selective inhibition of aromatase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

The pharmacology and clinical uses of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02841869009090018

10.3109/02841869009090018

21 January 2018

Identifiers

DOI

1 reference

release_dqdavr5fwzbtdoxbopqq4s2x7q

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dqdavr5fwzbtdoxbopqq4s2x7q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference